Low-dose aspirin use and cancer characteristics: A population-based cohort study

British Journal of Cancer

Volumn 109, Issue 7, 2013, Pages 1921-1925

  Jonsson, F ^a   Yin, L ^a   Lundholm, C ^a   Smedby, K E ^a   Czene, K ^a   Pawitan, Y ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

anti platelet therapy; low dose aspirin; tumour stage characteristics

Indexed keywords

ACETYLSALICYLIC ACID;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PROGNOSIS; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DISTANT METASTASIS; HUMAN; LOW DRUG DOSE; LUNG CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER; SWEDEN;

ADENOCARCINOMA; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; BREAST NEOPLASMS; COHORT STUDIES; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM METASTASIS; NEOPLASMS; PROSTATIC NEOPLASMS;

EID: 84885183806     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.411     Document Type: Article

References (15)

1. Barlow L, Westergren K, Holmberg L, Talback M (2009) The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol 48: 27-33.
2. Bastiaannet E, Sampieri K, Dekkers OM, de Craen AJ, van Herk-Sukel MP, Lemmens V, van den Broek CB, Coebergh JW, Herings RM, van de Velde CJ, Fodde R, Liefers GJ (2012) Use of aspirin postdiagnosis improves survival for colon cancer patients. Br J Cancer 106: 1564-1570.
3. Bosetti C, Rosato V, Gallus S, Cuzick J, La Vecchia C (2012) Aspirin and cancer risk: a quantitative review to 2011. Ann Oncol 23: 1403-1415.
4. Chan AT, Ogino S, Fuchs CS (2009) Aspirin use and survival after diagnosis of colorectal cancer. JAMA 302: 649-659.
5. Cook NR, Lee IM, Gaziano JM, Gordon D, Ridker PM, Manson JE, Hennekens CH, Buring JE (2005) Low-dose aspirin in the prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA 294: 47-55.
6. Egan KM, Stampfer MJ, Giovannucci E, Rosner BA, Colditz GA (1996) Prospective study of regular aspirin use and the risk of breast cancer. J Natl Cancer Inst 88: 988-993.
7. Holmes MD, Chen WY, Li L, Hertzmark E, Spiegelman D, Hankinson SE (2010) Aspirin intake and survival after breast cancer. J Clin Oncol 28: 1467-1472.
8. Jonsson H, Holmström B, Duffy SW, Stattin P (2011) Uptake of prostatespecific antigen testing for early prostate cancer detection in Sweden. Int J Cancer 129: 1881-1888.
9. Jurasz P, Alonso-Escolano D, Radomski MW (2004) Platelet-cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation. Br J Pharmacol 143: 819-826.
10. Rothwell PM, Fowkes FG, Belch JF, Ogawa H, Warlow CP, Meade TW (2011) Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomized trials. Lancet 377: 31-41.
11. Rothwell PM, Wilson M, Elwin CE, Norrving B, Algra A, Warlow CP, Meade TW (2010) Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow up of five randomized trials. Lancet 376: 1741-1750.
12. Rothwell PM, Wilson M, Price JF, Belch JF, Meade TW, Mehta Z (2012) Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomized trials. Lancet 379: 1591-1601.
13. Seshasai SRK, Wijesuriya S, Sivakumaran R, Nethercott S, Erqou S, Sattar N, Ray KK (2012) Effect of aspirin on vascular and nonvascular outcomes. Arch Intern Med 172: 209-216.
14. Thun MJ, Jacobs EJ, Patrono C (2012) The role of aspirin in cancer prevention. Nat Rev Clin Oncol 9: 259-267.
15. Wettermark B, Hammar N, Fored M, Leimanis A, Otterblad Olausson P, Bergman U, Persson I, Sundström A, Westerholm B, Rosén M (2007) The new Swedish Prescribed Drug Register-opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf 16: 726-735.